GLP-1 medications like semaglutide (Ozempic®) and tirzepatide (Mounjaro®) have already reshaped how we treat obesity and metabolic disease. But now, researchers are looking beyond dual agonists, and Retatrutide may be the most powerful compound yet.
Dubbed a “triple-hormone powerhouse,” Retatrutide is showing unprecedented results in early trials. In this post, we’ll explore what it is, how it works, clinical data, and what makes it a major step forward in weight-loss science.